Home › NDC Lookup › Ingredients › Glycerin 37.5%, Lanolin 12.5%, Lidocaine... › 70942-0517-75
🧴image loading
(from DailyMed)

Doctor Butler Hemorrhoid and Fissure Advanced Formula Glycerin 37.5%, Lanolin 12.5%, Lidocaine 4%, Zinc Oxide 5% 37.5 g/100g; 4 g/100g; 12.5 g/100g; 5 g/100g Ointment, 1 tube — NDC 70942-517-75 (Billing 70942-0517-75)

by Beyond Health, PA · 1 TUBE in 1 CARTON / 21.3 g in 1 TUBE

This is a package of 1 tube of Doctor Butler Hemorrhoid and Fissure Advanced Formula Glycerin 37.5%, Lanolin 12.5%, Lidocaine 4%, Zinc Oxide 5% 37.5 g/100g; 4 g/100g; 12.5 g/100g; 5 g/100g Ointment from Beyond Health, PA, marketed since Sep 2021 and currently FDA-listed.

NDC 70942-0517-75
🏷️ FDA NDC (as labeled) 70942-517-75 billing pads the product segment with a zero
This package
Contains1 tube Pack sizes2 compare ↓
Product page 70942-0517-01 Also comes in: 42.5 g 70942-517-01
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Aug 27, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 70942-517-75 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
70942 labeler · 517 product · 75 package
Package marketed since
Jul 22, 2025
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 7094251775 2
FDA record last changed
Aug 27, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 70942-517-75
Product NDC 70942-517
11-digit billing NDC 70942051775
NCPDP billing unit GM — per gram (weight)
RxCUI 2586855
UNII PDC6A3C0OX, 98PI200987, 7EV65EAW6H, SOI2LOH54Z
Application # M015
SPL Set ID d2a769e2-afd0-aed2-e053-2995a90ad429
Established class (EPC) Non-Standardized Chemical Allergen; Amide Local Anesthetic; Antiarrhythmic
Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production; Local Anesthesia
Chemical class Allergens; Glycerol; Amides
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-09-20
Route TOPICAL
Dosage form OINTMENT
Substance GLYCERIN; LIDOCAINE; LANOLIN; ZINC OXIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 088167
GCN 58261
HICL code 050834
Ingredient (HICL) Lidocaine/Zn/Lanolin/Glycerin
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q3
Therapeutic class — intermediate (HIC2) Anal-Rectal Preparations
HIC3 code Q3D
Therapeutic class — specific (HIC3) Hemorrhoidal Preparations
AHFS code 84:08.00.00
AHFS class Antipruritics And Local Anesthetics
FDB label name ADV HEMORRHOID-FISSURE OINT
FDB brand name Advanced Hemorrhoid-Fissure
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 088167
  • GCN: 58261
  • HICL (First Databank): 050834
  • AHFS class code: 84:08.00.00
  • RxCUI (RxNorm): 2586855
Why two NDCs? The FDA registers this code as 70942-517-75 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 70942-0517-75. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name ADV HEMORRHOID-FISSURE OINT Ingredient Lidocaine/Zn/Lanolin/Glycerin
🧪 What is this product?

Doctor Butler Hemorrhoid and Fissure Advanced Formula is a topical ointment sold as an over-the-counter product under FDA's monograph rules for hemorrhoid and fissure treatments. It contains glycerin and lanolin, which function as emollients and moisturizers to soften the affected area. Lidocaine is a local anesthetic typically used to numb discomfort, while zinc oxide is commonly included in products designed to protect and soothe irritated skin. The combination of these ingredients is intended for direct application to the affected area.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 42.5 g
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
70942-0517-01 70942-517-01 Main listing 1 TUBE in 1 CARTON / 42.5 g in 1 TUBE 2021-09-20 — Active
70942-0517-75 You're viewing this 1 TUBE in 1 CARTON / 21.3 g in 1 TUBE 2025-07-22 — Active

Pack size FAQ

What quantity is in this package?
This package contains 1 tube — 1 tube in 1 carton / 21.3 g in 1 tube.
How does this package differ from NDC 70942-0517-01?
Both are Doctor Butler Hemorrhoid and Fissure Advanced Formula Glycerin 37.5%, Lanolin 12.5%, Lidocaine 4%, Zinc Oxide 5% 37.5 g/100g; 4 g/100g; 12.5 g/100g; 5 g/100g Ointment — the drug itself is identical. This page's package is the 1 tube one, while NDC 70942-0517-01 is the 1 tube package.
What NDC number is used to bill for this package of Doctor Butler Hemorrhoid and Fissure Advanced Formula Glycerin 37.5%, Lanolin 12.5%, Lidocaine 4%, Zinc Oxide 5% 37.5 g/100g; 4 g/100g; 12.5 g/100g; 5 g/100g Ointment?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Doctor Butler Hemorrhoid and Fissure Advanced Formula 37.5 g/100g; 4 g/100g; 12.5 g/100g; 5 g/100gthis 70942-0517-75 Beyond 1 tube — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Sep 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerBeyond Health, PA
FDA applicationM015 (OTC MONOGRAPH DRUG)
Labeler code70942
First marketedSep 2021
Product typeHuman Otc Drug
Portfolio2 products on file

More NDCs from Beyond Health, PA labeler code 70942

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 13 words ▾

Uses helps relieve the local or anorectal itching and discomfort associated with hemorrhoids

⏱️ Dosage and Administration 64 words ▾

Directions adults; when practical, cleanse the affected area by patting or blotting with an appropriate cleansing wipe. Gently dry by patting or blotting with a tissue or soft cloth before appying the ointment apply externally to the affected area up to 4 times daily, especially at night, in the morning or after each bowel movement children under 12 years of age consult your pediatrician

⚠️ Warnings 117 words ▾

Warnings For external use only inclluding the skin of the anal canal When using this product do not exceed the recommended daily dosage unless directed by a doctor do not put this product into the rectum by using fingers or any mechanical device or applicator Stop use and ask a doctor if condition worsens or does not improve within seven (7) days bleeding occurs an allergic reaction develops the symptom being treated does not subside or if redness, irritation, swelling, pain or other symptoms develop or increase If pregnant or breast-feeding ask a health care professional before use.

Keep out of reach of children If swallowed, seek medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 11 words ▾

Active ingredients Glycerin 37.5% Lanolin 12.5% Lidocaine 4.0% Zinc Oxide 5.0%

🧪 Inactive Ingredients 121 words ▾

Inactive ingredients Aesculus Hippocastanum (Horse Chestnut) Extract Argania Spinosa Kernel Oil Calendula Officinalis Flower Extract Camellia Sinensis Leaf Extract Cananga Odorata Flower Oil (organic) Canola Oil Caprylic/Capric Triglyceride Centella Asiatica Extract Chamomilla Recutita (Matricaria) Flower Extract Cocos Nucifera (Coconut) Oil Curcuma Longa (Turmeric) Root Extract Dunaliella Salina Extract Euphorbia Cerifera (Candelilla) Wax Helianthus Annuus (Sunflower) Seed Oil Helianthus Annuus (Sunflower) Seed Wax Hydrocortisone Lavandula Angustifolia (Lavender) Oil Linum Usitatissimum (Linseed) Seed Oil Lysine HCl Macadamia Ternifolia Seed Oil Olea Europaea (Olive) Fruit Oil Panax Ginseng Root Extract Persea Gratissima (Avocado) Oil Pogostemon Cablin Oil (organic) Polyhydroxystearic Acid Punica Granatum Fruit Extract Ricinus Communis (Castor) Seed Oil Rosa Canina Seed Oil (organic) Sodium Hyaluronate Tocopheryl Acetate Triethoxycaprylylsilane Viburnum Opulus Bark Extract Water

🎯 Purpose 7 words ▾

Purpose Protectant Protectant Analgesic (pain relief) Astringent

📄 When Using This Product 33 words ▾

When using this product do not exceed the recommended daily dosage unless directed by a doctor do not put this product into the rectum by using fingers or any mechanical device or applicator

📄 Stop Use and Ask a Doctor If 42 words ▾

Stop use and ask a doctor if condition worsens or does not improve within seven (7) days bleeding occurs an allergic reaction develops the symptom being treated does not subside or if redness, irritation, swelling, pain or other symptoms develop or increase

🤰 If Pregnant or Breast-Feeding 11 words ▾

If pregnant or breast-feeding ask a health care professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children If swallowed, seek medical help or contact a Poison Control Center right away.

📄 Package Label / Principal Display Panel 5 words ▾

0.75oz / 21.3g tube pdp

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos — Not published for this NDC No photo available yet for this listing.
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Beyond Health, PA. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 1 tube (70942-0517-01). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Beyond Health, PA is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 70942-0357-01 · Beyond 70947-0010-04 · Worldwide →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.